[{"id":"e1789d3b-7f73-4e03-8844-1658c55f879a","acronym":"","url":"https://clinicaltrials.gov/study/NCT01704274","created_at":"2021-01-18T07:25:02.274Z","updated_at":"2024-07-02T16:35:23.730Z","phase":"Phase 2","brief_title":"GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy","source_id_and_acronym":"NCT01704274","lead_sponsor":"Dr. D. Robert Siemens","biomarkers":" PD-L1 • TGFB1 • ULBP2","pipe":"","alterations":" ","tags":["PD-L1 • TGFB1 • ULBP2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e nitroglycerin"],"overall_status":"Completed","enrollment":" Enrollment 43","initiation":"Initiation: 04/01/2012","start_date":" 04/01/2012","primary_txt":" Primary completion: 01/01/2017","primary_completion_date":" 01/01/2017","study_txt":" Completion: 12/01/2019","study_completion_date":" 12/01/2019","last_update_posted":"2024-01-11"}]